Cassava Sciences Inc vs abrdn Physical Palladium Shares ETF — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while abrdn Physical Palladium Shares ETF trades at $25.03. The key difference: abrdn Physical Palladium Shares ETF is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | PALL | |
|---|---|---|
Market Cap | $47.75M | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $4.64 | $37.18 |
52-Week Low | $0.87 | $19.96 |
Enterprise Value | -$34.93M | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
PALL trades at $25.05, up 0.64% with bullish technical signals from moving averages. The stock recently underwent a 1:5 split on May 18, 2026. Technical indicators show mixed signals with RSI suggesting mild overbought conditions while ADX indicates strong trend strength. Support and resistance levels cluster around $25-$26, creating a key price zone.
PALL presents a contrarian opportunity as palladium prices remain 47% below January 2026 highs. Supply risks and industrial demand support long-term fundamentals, though the ETF faces commodity price volatility and Federal Reserve policy uncertainty as near-term headwinds.
Trailing returns across standard periods
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →PALL is a physically-backed ETF that tracks the spot price of palladium. It holds physical bullion in secure vaults, offering a liquid way to invest in this precious metal primarily used in automotive catalytic converters and electronics.
Read more on PALL →